Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-12-10 Sale | 2021-12-10 8:43 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 35,000 | $102.55 | $3,589,146 | 94,988 (Direct) | View |
2020-06-10 Sale | 2020-06-12 5:19 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 73,725 | $66.09 | $4,872,602 | 24,294 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-10-03 Disposition | 2022-10-03 8:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 15,900 | $148.5 | 0 (Direct) | View |
2022-10-03 Disposition | 2022-10-03 8:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 383,506 | $0 | 0 (Direct) | View |
2022-01-07 Tax Withholding | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 1,279 | $128.87 | 71,923 (Direct) | View |
2022-01-06 Exercise | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 7,000 | $0 | 71,923 (Direct) | View |
2022-01-07 Option Award | 2022-01-07 9:17 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 39,000 | $0 | 71,923 (Direct) | View |
2022-01-06 Tax Withholding | 2022-01-07 9:17 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 1,532 | $123.86 | 71,923 (Direct) | View |
2021-12-10 Exercise | 2021-12-10 8:43 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 35,000 | $0 | 94,988 (Direct) | View |
2021-11-25 Exercise | 2021-11-26 4:29 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 3,700 | $0 | 14,896 (Direct) | View |
2021-11-25 Tax Withholding | 2021-11-26 4:29 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 1,715 | $115.55 | 14,896 (Direct) | View |
2021-01-06 Exercise | 2021-01-08 8:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 3,750 | $0 | 65,461 (Direct) | View |
2021-01-06 Option Award | 2021-01-08 8:48 pm | N/A 2031-01-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 45,000 | $0 | 65,461 (Direct) | View |
2021-01-06 Tax Withholding | 2021-01-08 8:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 1,747 | $83.38 | 65,461 (Direct) | View |
2020-11-25 Exercise | 2020-11-27 9:47 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 3,700 | $0 | 13,944 (Direct) | View |
2020-11-25 Tax Withholding | 2020-11-27 9:47 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 1,678 | $90.14 | 13,944 (Direct) | View |
2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A 2026-12-14 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 73,725 | $0 | 24,294 (Direct) | View |
2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 25,000 | $5.6 | 24,294 (Direct) | View |
2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 31,225 | $9.29 | 24,294 (Direct) | View |
2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 17,500 | $0.61 | 24,294 (Direct) | View |
2019-12-18 Exercise | 2019-12-20 9:39 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 3,700 | $0 | 15,622 (Direct) | View |
2019-12-18 Tax Withholding | 2019-12-20 9:39 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 1,678 | $52.13 | 15,622 (Direct) | View |
2019-11-25 Option Award | 2019-11-27 9:29 pm | N/A 2029-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer | 44,300 | $0 | 44,300 (Direct) | View |